diaTribe Foundation

What diaTribe Foundation does

diaTribe Foundation is a 501(c)(3) nonprofit organization founded in 2006 by Kelly Close, who has lived with diabetes for over 35 years. Headquartered at 2352 Market Street in San Francisco, the foundation operates diaTribe Learn, a free digital publication providing expert-reviewed diabetes education covering Type 1, Type 2, prediabetes, and gestational diabetes through articles, recipes, wellness guides, and a weekly newsletter distributed to more than 600,000 subscribers, reaching over 6 million people annually. The foundation also runs three specialized programs: dStigmatize (launched 2022), which addresses diabetes stigma; the Time in Range Coalition (formed 2023), a multi-stakeholder initiative convening 30 international organizations to establish time in range as a standard diabetes care metric; and diaTribe Musings, an event series convening diabetes experts, clinicians, and policymakers.

The organization's underlying technology is a digital content platform comprising diatribe.org and dedicated sub-brand websites (dstigmatize.org, timeinrange.org) supported by email newsletter infrastructure and an active social media presence across Twitter/X, Facebook, LinkedIn, Instagram, TikTok, YouTube, and a Facebook Group. diaTribe has increasingly positioned itself as a clinical and regulatory consensus convener, publishing the first international consensus on CGM and AID use during pregnancy in The Lancet Diabetes & Endocrinology in January 2026 (endorsed by 25 global healthcare organizations) and an international consensus on off-label GLP-1 use in Type 1 diabetes in Diabetes Technology & Therapeutics in June 2026 (endorsed by AACE, Breakthrough T1D, and ISPAD). The foundation also partners with industry on awareness campaigns, including a 2026 'All Eyes on DME' campaign with Genentech.

diaTribe generates revenue exclusively through donations, philanthropy, and corporate sponsorships as a 501(c)(3) nonprofit (EIN 46-2431517). All content and programs are provided free of charge to people with diabetes and their families, with giving mechanisms including online donations, gifts of stock, IRA qualified charitable distributions, legacy giving, and donor-advised fund contributions. The organization maintains relationships with pharmaceutical and healthcare technology companies for event and program sponsorship, and is led by CEO Jim Carroll, Founder Kelly Close, and a board of senior diabetes clinicians, researchers, and industry executives.

Name

diaTribe Foundation

Legal name

The diaTribe Foundation

Website

https://diatribe.org

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

diaTribe Foundation is a San Francisco-based 501(c)(3) nonprofit that publishes free diabetes education and advocacy content to over 6 million people annually via its website, 600,000+ subscriber newsletter, and programs including the Time in Range Coalition and dStigmatize.

Ownership category

akta.pro rank

Product category

Patient Diabetes Education

NAICS

Voluntary Health Organizations (813212)

SIC

Miscellaneous Publishing (2741)

akta.pro primary industry

Public Charities & Grantmaking Intermediaries (BPAGAKAE)

akta.pro secondary industry

Health Research Funding Agencies (Public/Quasi-Public) (HLAJALAB)

Keywords

• Diabetes education
• Patient advocacy
• Health content publishing
• Nonprofit health programs
• Diabetes community

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations

Revenue model

1. Donations and Philanthropy: diaTribe Foundation is a 501(c)(3) nonprofit organization (EIN: 46-2431517). It generates revenue through donations from individuals, corporate social responsibility funds, and philanthropic grants. The organization offers multiple giving mechanisms including offline donations, gifts of stock/securities, IRA qualified charitable distributions, legacy giving through wills or estate plans, and donor-advised fund contributions.
2. Sponsorships and Corporate Partnerships: Corporate sponsors support diaTribe's events and programs, with the organization maintaining relationships with pharmaceutical and healthcare technology companies. Sponsors are mentioned in the context of event registration, where employees of sponsoring companies are directed to contact the Development Manager for streamlined registration.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

diaTribe Foundation is a 501(c)(3) nonprofit organization that produces diabetes-focused educational content, advocacy campaigns, and community programs. It operates digital platforms such as diaTribe Learn and dStigmatize and convenes coalitions such as the Time in Range Coalition to advance knowledge, reduce stigma, and improve outcomes for people living with diabetes.

Product overview

The diaTribe Foundation operates diaTribe Learn as its primary digital publication providing diabetes education and news, supported by specialized programs including dStigmatize (stigma reduction), the Time in Range Coalition (advocacy for glucose monitoring metrics), and diaTribe Musings (expert panel events). The organization functions as a nonprofit educational and advocacy entity rather than a commercial technology product company, focused on helping people with diabetes and prediabetes live happier and healthier lives through accessible information and community engagement.

Differentiator

Problem solved

Functional benefit

Brands

• dStigmatize: A program focused on reducing the impact of diabetes on society by fostering understanding of the disease, eliminating misplaced blame, and ensuring access to care.
• Time in Range Coalition
• Musings

Products and services

• diaTribe Learn Educational program providing diabetes knowledge and resources for people living with diabetes and prediabetes.
• dStigmatize Advocacy and awareness program focused on reducing stigma experienced by people with diabetes.
• Time in Range Coalition Coalition program that convenes stakeholders to promote Time in Range as a standard metric in diabetes management.
• diaTribe Musings Editorial content series providing commentary and reflections on diabetes care, policy, and lived experience.

Quantifiable outcome

• diaTribe newsletters reach more than 600,000 people with diabetes and their families weekly.
• +2 more outcomes

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered core.

• American Association of Clinical Endocrinology (AACE)coreStrategic or Co-development Partner · 5 June 2026diaTribe convened an international consensus on the off-label use of GLP-1 and GLP-1/GIP receptor agonists in type 1 diabetes management. The consensus statement was published in Diabetes Technology & Therapeutics, chaired by Dr. Satish Garg, and includes 35 recommendations covering benefits, initiation and titration protocols, screening, monitoring, and risk mitigation. The recommendations were endorsed by AACE along with Breakthrough T1D and the International Society for Pediatric and Adolescent Diabetes.
• Breakthrough T1D (formerly JDRF)coreStrategic or Co-development Partner · 5 June 2026diaTribe convened an international consensus on the off-label use of GLP-1 and GLP-1/GIP receptor agonists in type 1 diabetes management. The consensus statement was published in Diabetes Technology & Therapeutics, chaired by Dr. Satish Garg, and includes 35 recommendations covering benefits, initiation and titration protocols, screening, monitoring, and risk mitigation. The recommendations were endorsed by Breakthrough T1D along with AACE and the International Society for Pediatric and Adolescent Diabetes.
• International Society for Pediatric and Adolescent Diabetes (ISPAD)coreStrategic or Co-development Partner · 5 June 2026diaTribe convened an international consensus on the off-label use of GLP-1 and GLP-1/GIP receptor agonists in type 1 diabetes management. The consensus statement was published in Diabetes Technology & Therapeutics, chaired by Dr. Satish Garg, and includes 35 recommendations covering benefits, initiation and titration protocols, screening, monitoring, and risk mitigation. The recommendations were endorsed by ISPAD along with AACE and Breakthrough T1D.
• Genentech (Roche Group)coreGTM or Marketing Partner · 24 April 2026Genentech launched the 'All Eyes on DME' campaign in partnership with diaTribe and comedian Damon Wayans to educate people about diabetic macular edema, a serious eye condition affecting 750,000 people in the U.S. The campaign uses humor to address health disparities and provides resources including symptom information, patient tools, and doctor conversation guides through AllEyesonDME.com. People of color are two to three times more likely to develop sight-threatening diabetes-related conditions.
• 25 Leading Global Healthcare OrganizationscoreStrategic or Co-development Partner · 12 January 2026diaTribe convened and published the first international consensus statement on the use of continuous glucose monitoring (CGM) and automated insulin delivery (AID) technologies during pregnancy, published in The Lancet Diabetes & Endocrinology. The consensus was developed by experts across six continents and endorsed by 25 leading global healthcare organizations. The statement provides 14 specific recommendations to standardize technology use during preconception, pregnancy, labor, delivery, and the postpartum period, with the goal of improving maternal health outcomes and increasing device access and user confidence.
• Time in Range Coalition (30 International Organizations)coreStrategic or Co-development PartnerThe Time in Range Coalition was formed by diaTribe Foundation with a multi-stakeholder group of foundations, nonprofit organizations, researchers, people with diabetes, clinicians, and industry partners. The goal is to establish time in range as an essential part of diabetes care and to make time in range accessible to all people with diabetes and their care teams. This involves work in regulatory, clinical, research, and patient education areas.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Joslin Diabetes Center: Harvard-affiliated diabetes clinical care, research, and education organization sharing board leadership talent (former CMO Dr. Alan Moses; former CEO Dr. Roberta Herman) with diaTribe and overlapping convening role.

Emerging players

• T1D Exchange: Type 1 diabetes research network and patient/clinician community with partial overlap in research convening and patient education focus.
• Health Union: Digital health community platform operating condition-specific patient communities (including diabetes); comparable digital content, sponsorship-driven, and patient-engagement model.
• College Diabetes Network: Nonprofit supporting young adults with diabetes through college and early career; niche overlap with diaTribe's caregiver and young-adult segments.

Direct peers

• Beyond Type 1: Diabetes nonprofit that operates a digitally-led content, community, and advocacy platform across type 1 and type 2 diabetes with a comparable audience and GTM motion.
• Breakthrough T1D (formerly JDRF): Leading type 1 diabetes research and advocacy organization; a current diaTribe consensus partner (GLP-1 in type 1 consensus) with overlapping editorial and advocacy scope.
• American Diabetes Association: The largest US diabetes nonprofit providing patient education, professional resources, advocacy, and research funding — the closest direct peer to diaTribe with overlapping mission, audience, and content channels.
• Diabetes Research Institute Foundation: Diabetes-focused nonprofit funding cure-oriented research and providing patient education; comparable audience, donor-base structure, and nonprofit revenue model.

Regional players

• Diabetes UK: Leading UK diabetes charity providing patient education, research funding, and advocacy — a comparable mission and content offering but operating primarily in the UK market.

Others

• dQ&A: Diabetes patient and physician market research firm founded by Kelly Close (also diaTribe's founder); closely affiliated sister entity providing proprietary data to pharma and adjacent to diaTribe's editorial operations.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks4 records

Key highlights6 records

Customer concentration

• Xx.com/diatribenews
• YouTubeyoutube.com/@diatribenews
• Facebookfacebook.com/diaTribeNews
• LinkedInlinkedin.com/company/the-diatribe-foundation
• Instagraminstagram.com/diatribenews
• TikToktiktok.com/@diatribenews

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about diaTribe Foundation